PACS PACS Group
- 30.040
- -0.430-1.41%
- 29.990
- -0.050-0.17%
PACS Group News
Pacs Group Inc: Stephens raised price target from $33 to $35
Pacs Group Inc: Stephens raised price target from $33 to $35
Express News | Pacs Group Inc : Stephens Raises Target Price to $35 From $33
Express News | NYSE Order Imbalance 50847.0 Shares on Buy Side
PACS Group Shares Are Trading Higher After the Company Announced That It Agreed to Acquire the Operations of 53 Nursing and Assisted/independent Living Facilities and Will Lease 37 Facilities From a Joint Venture.
PACS Group Shares Are Trading Higher After the Company Announced That It Agreed to Acquire the Operations of 53 Nursing and Assisted/independent Living Facilities and Will Lease 37 Facilities From a J
Truist Financial Maintains PACS Group(PACS.US) With Buy Rating
Truist Financial analyst David S Macdonald maintains $PACS Group(PACS.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 63.9% and a total average return of 13.1% ove
Truist Financial Issues a Buy Rating on PACS Group Inc (PACS)
PACS Group to Acquire Operations of 53 Nursing Homes in US
PACS Group (PACS) said late Wednesday it has agreed to acquire the operations of 53 skilled nursing and assisted living facilities located in eight western states. The facilities are operated by famil
Express News | Pacs Group Announces Pending Acquisition of Operations at 53 Facilities in Pacific Northwest, Real Estate Joint Venture on Majority of the Locations
PACS Group | 10-Q/A: Quarterly report (Amendment)
Truist Securities Maintains Buy on PACS Group, Maintains $32 Price Target
Truist Securities analyst David Macdonald maintains PACS Group (NYSE:PACS) with a Buy and maintains $32 price target.
Royal Bank of Canada: Maintaining the PACS Group (PACS.US) rating, adjusted from superior to superior market rating, and adjusted the target price from $30.00 to $32.00.
Royal Bank of Canada: Maintaining the PACS Group (PACS.US) rating, adjusted from superior to superior market rating, and adjusted the target price from $30.00 to $32.00.
PACS Group Is Maintained at Outperform by Oppenheimer
PACS Group Is Maintained at Outperform by Oppenheimer
Oppenheimer Maintains Outperform on PACS Group, Raises Price Target to $32
Oppenheimer analyst Michael Wiederhorn maintains PACS Group (NYSE:PACS) with a Outperform and raises the price target from $31 to $32.
RBC Raises Price Target on PACS Group to $32 From $30, Keeps Outperform Rating
PACS Group (PACS) has an average investment rating of buy among analysts polled by Capital IQ, with price targets ranging from $27 to $34. Price: 26.90, Change: -0.01, Percent Change: -0.04
Analysts Have Conflicting Sentiments on These NA Companies: Metagenomi, Inc. (MGX), Smith Douglas Homes Corp. Class A (SDHC) and PACS Group Inc (PACS)
Analysts Are Bullish on Top NA Stocks: American Healthcare REIT, Inc. (AHR), PACS Group Inc (PACS)
Stephens & Co. : The PACS Group (PACS.US) rating was reaffirmed and adjusted from an increase in holdings to an increase in holdings rating, with a target price of $31.00.
Stephens & Co. : The PACS Group (PACS.US) rating was reaffirmed and adjusted from an increase in holdings to an increase in holdings rating, with a target price of $31.00.
Stephens & Co. Reiterates Overweight on PACS Group, Maintains $31 Price Target
Stephens & Co. analyst Scott Fidel reiterates PACS Group (NYSE:PACS) with a Overweight and maintains $31 price target.
PACS Group Beats Top-line and Bottom-line Estimates; Initiates FY24 Outlook
PACS Group Q1 Earnings, Revenue Increase
PACS Group (PACS) reported Q1 earnings late Monday of $0.38 per diluted share, up from $0.29 a year earlier. Two analysts polled by Capital IQ expected $0.30. Revenue for the quarter ended March 31 wa
Analysis
Price Target
No Data
